JOSÉ LUIS
CALLEJAS RUBIO
PROFESOR PERMANENTE LABORAL
![Foto de JOSÉ LUIS](/img/nophoto.png)
![Foto de Instituto de Parasitología y Biomedicina López Neyra](/img/noimage_org.png)
Instituto de Parasitología y Biomedicina López Neyra
Armilla, EspañaPublicaciones en colaboración con investigadores/as de Instituto de Parasitología y Biomedicina López Neyra (40)
2024
-
Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study
The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383
-
Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4+ T cells in giant cell arteritis
Journal of Autoimmunity, Vol. 142
2023
-
Contribution of Telomere Length to Systemic Sclerosis Onset: A Mendelian Randomization Study
International Journal of Molecular Sciences, Vol. 24, Núm. 21
-
Identification of Mechanisms by Which Genetic Susceptibility Loci Influence Systemic Sclerosis Risk Using Functional Genomics in Primary T Cells and Monocytes
Arthritis and Rheumatology, Vol. 75, Núm. 6, pp. 1007-1020
-
Identification of new risk loci shared across systemic vasculitides points towards potential target genes for drug repurposing
Annals of the Rheumatic Diseases, Vol. 82, Núm. 6, pp. 837-847
-
Non-classical circulating monocytes expressing high levels of microsomal prostaglandin E2 synthase-1 tag an aberrant IFN-response in systemic sclerosis
Journal of Autoimmunity, Vol. 140
2022
-
Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis
npj Genomic Medicine, Vol. 7, Núm. 1
-
The Effect of Body Fat Distribution on Systemic Sclerosis
Journal of Clinical Medicine, Vol. 11, Núm. 20
2021
-
Fibroblast growth factor-23 is associated with high-density lipoprotein in systemic sclerosis female patients
Phillippine Journal of Internal Medicine, Vol. 59, Núm. 1, pp. 9-13
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
2017
-
An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis
Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457
2016
-
Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated with Visceral Leishmaniasis
American Journal of Therapeutics, Vol. 23, Núm. 5, pp. e1193-e1196
2015
-
Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis
Clinical and Experimental Rheumatology, Vol. 33, pp. 31-35
2013
-
Increased CD38 expression in T cells and circulating anti-CD38 IgG autoantibodies differentially correlate with distinct cytokine profiles and disease activity in systemic lupus erythematosus patients
Cytokine, Vol. 62, Núm. 2, pp. 232-243
-
New insight on the Xq28 association with systemic sclerosis
Annals of the Rheumatic Diseases, Vol. 72, Núm. 12, pp. 2032-2038
-
Preferential Binding to Elk-1 by SLE-Associated IL10 Risk Allele Upregulates IL10 Expression
PLoS Genetics, Vol. 9, Núm. 10
2012
-
Altered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in Systemic Lupus Erythematosus patients
Mediators of Inflammation, Vol. 2012
-
Analysis of autosomal genes reveals gene-sex interactions and higher total genetic risk in men with systemic lupus erythematosus
Annals of the Rheumatic Diseases, Vol. 71, Núm. 5, pp. 694-699
-
Association between -174 interleukin-6 gene polymorphism and biological response to rituximab in several systemic autoimmune diseases
DNA and Cell Biology, Vol. 31, Núm. 9, pp. 1486-1491
-
Genetic and physical interaction of the B-cell systemic lupus erythematosus-associated genes BANK1 and BLK
Annals of the Rheumatic Diseases, Vol. 71, Núm. 1, pp. 136-142